Related Experiment Video
Updated: Jul 18, 2026
06:32
Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
Published on: October 24, 2016
Treatment of oncologic emergencies
Mark L Higdon1, Jennifer A Higdon
1Martin Army Community Hospital Family Medicine Residency Program, Fort Benning, Georgia, USA. higdon@mac.com
American Family Physician
|December 16, 2006
Summary
Oncologic emergencies, including metabolic, hematologic, and structural types, require prompt management. Understanding these conditions and their treatments is crucial for improving patient outcomes in oncology.
Area of Science:
- Oncology
- Emergency Medicine
- Internal Medicine
Background:
- Oncologic emergencies are critical conditions requiring immediate medical attention.
- These emergencies can be broadly categorized into metabolic, hematologic, structural, or chemotherapy-related complications.
Purpose of the Study:
- To provide a comprehensive overview of common oncologic emergencies.
- To summarize the diagnostic features and management strategies for various oncologic emergencies.
Main Methods:
- Review of common oncologic emergencies including tumor lysis syndrome, hypercalcemia, SIADH, febrile neutropenia, hyperviscosity syndrome, SVC syndrome, spinal cord compression, and malignant pericardial effusion.
- Discussion of diagnostic criteria and treatment modalities for each condition.
Main Results:
- Metabolic emergencies like tumor lysis syndrome and hypercalcemia have specific electrolyte and fluid management protocols.
- Hematologic emergencies such as febrile neutropenia necessitate prompt antibiotic therapy.
- Structural emergencies including superior vena cava syndrome and spinal cord compression require interventions like chemotherapy, radiation, or surgery.
Conclusions:
- Effective management of oncologic emergencies relies on accurate classification and timely intervention.
- Multidisciplinary approaches are often necessary for optimal patient care and outcomes.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...